[go: up one dir, main page]

SE9002342D0 - Medicament - Google Patents

Medicament

Info

Publication number
SE9002342D0
SE9002342D0 SE9002342A SE9002342A SE9002342D0 SE 9002342 D0 SE9002342 D0 SE 9002342D0 SE 9002342 A SE9002342 A SE 9002342A SE 9002342 A SE9002342 A SE 9002342A SE 9002342 D0 SE9002342 D0 SE 9002342D0
Authority
SE
Sweden
Prior art keywords
medicament
opo3h2
combatting
alleviating
preparing
Prior art date
Application number
SE9002342A
Other languages
English (en)
Other versions
SE467340B (sv
Original Assignee
Perstorp Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp Ab filed Critical Perstorp Ab
Priority to SE9002342A priority Critical patent/SE467340B/sv
Publication of SE9002342D0 publication Critical patent/SE9002342D0/sv
Priority to PCT/SE1991/000466 priority patent/WO1992000744A1/en
Priority to AU82253/91A priority patent/AU8225391A/en
Publication of SE467340B publication Critical patent/SE467340B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9002342A 1990-07-04 1990-07-04 Anvaendning av inositolmonofosfat foer framstaellning av ett laekemedel effektivt som en neuropeptid y-(npy-)antagonist SE467340B (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9002342A SE467340B (sv) 1990-07-04 1990-07-04 Anvaendning av inositolmonofosfat foer framstaellning av ett laekemedel effektivt som en neuropeptid y-(npy-)antagonist
PCT/SE1991/000466 WO1992000744A1 (en) 1990-07-04 1991-06-27 THE USE OF INOSITOLMONOPHOSPHATE FOR THE PREPARING OF A MEDICAMENT EFFECTIVE AS A NEUROPEPTIDE η-ANTAGONIST
AU82253/91A AU8225391A (en) 1990-07-04 1991-06-27 The use of inositolmonophosphate for the preparing of a medicament effective as a neuropeptide gamma-antagonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002342A SE467340B (sv) 1990-07-04 1990-07-04 Anvaendning av inositolmonofosfat foer framstaellning av ett laekemedel effektivt som en neuropeptid y-(npy-)antagonist

Publications (2)

Publication Number Publication Date
SE9002342D0 true SE9002342D0 (sv) 1990-07-04
SE467340B SE467340B (sv) 1992-07-06

Family

ID=20379939

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9002342A SE467340B (sv) 1990-07-04 1990-07-04 Anvaendning av inositolmonofosfat foer framstaellning av ett laekemedel effektivt som en neuropeptid y-(npy-)antagonist

Country Status (3)

Country Link
AU (1) AU8225391A (sv)
SE (1) SE467340B (sv)
WO (1) WO1992000744A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2126212A1 (en) * 1991-12-19 1993-07-08 Albert Tseng A novel molecule which inhibits neuropeptide tyrosine biological function
US5550166A (en) * 1995-03-17 1996-08-27 Ostlund; Richard E. Pinitol and derivatives thereof for the treatment of metabolic disorders
JP4106711B2 (ja) * 1996-03-21 2008-06-25 萬有製薬株式会社 アミノピリジン誘導体
FR2754709B1 (fr) * 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
IL122077A0 (en) * 1997-10-30 1998-03-10 Univ Ben Gurion Epi-inositol compositions for the treatment of CNS disorders
AU5277000A (en) 1999-05-20 2000-12-12 Humanetics Corporation Stimulating transport of glucose into animal tissue by the administration of pinitol
KR20040051455A (ko) * 2002-12-12 2004-06-18 아미코젠주식회사 산화적 손상을 예방하기 위한 카이로이노시톨 또는피니톨의 용도 및 이들을 함유하는 당뇨합병증 예방용조성물
KR20040084168A (ko) * 2003-03-26 2004-10-06 아미코젠주식회사 피니톨 또는 카이로이노시톨을 포함하는 간 질환 예방 및치료용 조성물
EP1858519B1 (de) 2005-03-12 2013-02-20 Bitop Aktiengesellschaft Für Biotechnische Optimierung Ectoin und/oder hydroxyectoin zur prophylaxe und behandlung chronisch entzündlicher darmerkrankungen
DE102008039231A1 (de) 2008-08-22 2010-02-25 Bitop Ag Verwendung von Glucosylglycerol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211956A (en) * 1988-05-19 1993-05-18 Sanwa Kagaku Kenkyusho Co., Ltd. Pharmaceutical compositions containing phytic acid or its salts
JPH01294631A (ja) * 1988-05-19 1989-11-28 Sanwa Kagaku Kenkyusho Co Ltd 糖尿性疾患治療予防剤及び飲食、し好物
US5041429A (en) * 1988-06-01 1991-08-20 Sanwa Kagaku Kenkyusho Co., Ltd. Cell activators, circulatory ameliorators and edible compositions
SE464059C (sv) * 1988-09-15 1997-06-02 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel
JPH02289592A (ja) * 1989-04-28 1990-11-29 Sanwa Kagaku Kenkyusho Co Ltd 新規組成物及びその用途

Also Published As

Publication number Publication date
WO1992000744A1 (en) 1992-01-23
SE467340B (sv) 1992-07-06
AU8225391A (en) 1992-02-04

Similar Documents

Publication Publication Date Title
GB2255505A (en) Use of inositolphosphates for preparing medicament
DE69230144D1 (de) Röntgenkontrastmittel
AR042262A2 (es) Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis
MX9701538A (es) Sales de un derivado del indol contra la migraña.
SE8904354D0 (sv) A pharmaceutical composition
AU554227B2 (en) Vicinal dihydroxyalkylxanthine derivatives
SE9002342D0 (sv) Medicament
EP0310305A3 (en) Cathartics
BR9506552A (pt) Método de inibição de integrase retroviral
GR3019760T3 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ES2085898T3 (es) Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina.
SE9303853D0 (sv) The use of an ester of inositoltrisphosphate for the preparing of medicaments
SE9404568D0 (sv) The use of inositoltrisphosphate for the preparing of medicaments
FI915245A0 (fi) 7-acyl-3-(substitueradkarbamoyloxi) cefemfoereningar samt foerfarande foer framstaellning av dessa.
MY102506A (en) Improvements in or relating to fungicides
ES511365A0 (es) "procedimiento de preparacion de derivados de fenetanolamina".
EP0317933A3 (en) Treatment of fibromyalgia
DE3362876D1 (en) Dibenzocycloheptenylidene compounds for use in modulating the immune response
GR3022217T3 (en) Treatment of cataract with prostacyclin compounds
EP0260606A3 (en) Medicament for curing neurotic disturbance or disorder comprising sialocylglycerolipid
FR2398499A1 (fr) Nouvelles compositions pharmaceutiques a base de derives de l'imidazole pour inhiber la secretion de la prolactine
FR2427325A1 (fr) Derives de l'alanine possedant des proprietes fongicides, leur preparation et leurs utilisations
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments
IT1245631B (it) Impiego di composti macrolidi come agenti anti-infiammatori per il trattamento di malattie provocate da cessione di istamina
ZA841850B (en) 2'-desoxyoxanosine,a process for the preparation thereof and its use as a medicament

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 9002342-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 9002342-5

Format of ref document f/p: F